DevOps Engineer, Aizon
Data analysis for life sciences manufacturers
Job no longer available
Data analysis for life sciences manufacturers
101-200 employees
Job no longer available
101-200 employees
Company mission
To bring safe, high quality and effective drugs to patients.
Jump to section
Company mission
To bring safe, high quality and effective drugs to patients.
Our take
In the pharmaceutical manufacturing sector, arduous testing phases and lengthy clinical studies are a necessity. However, the development of urgent drugs is made even longer by inefficient data management and the slow optimisation of large-scale manufacturing processes.
Aizon is a company that serves pharmaceutical manufacturers with a GxP compliant predictive analytics platform. Its suite of solutions leverage industrialised AI to produce insights that can help improve processes, provide transparency, and deliver drugs quickly and on budget.
The company has seen funding to the sum of over $40 million, testament to the the value the industry sees in its proposition. Aizon’s most recent round of funding will be used to execute its strategic roadmap, which includes significant scaling and the acceleration of its development pipeline.
Freddie
Company Specialist at Welcome to the Jungle
Benefits
- Stock options
- Health insurance
- Work life balance
- Continuous education
Funding (last 2 of 4 rounds)
Feb 2024
$20m
SERIES C
Nov 2019
$15m
SERIES B
Total funding: $43.7m
This company has top investors
Leadership
Pep Gubau
(CEO & CTO)Previously CEO at gnuine and Physis.
Toni Manzano
(CSO)Currnetly Member of the Parenteral Drug Association, International Expert on 4IR in Biopharma for UNIDO, Lecturer at Universitat Rovira i Virgili, and Lecturer at OBS Business School.
Pere Merino
(Board Director)Currently Board Member and Director at Kiin, Chairman and Co-Founder at HONEXT. Previously Co-Founder at ABEMER&SONS, and Founder and President at Fundació Hope Projects.